Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T.
Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
1985
ISSN/ISBN: 0047-1860 PMID: 3858562 Document Number: 245873
Document emailed within 1 workday
Related Documents
Suzuki, M.; Sekiguchi, I.; Ohwada, M.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA 125 associated with ovarian cancer. (IV) Serum CA 125 levels through normal menstrual cycle and in benign diseases Rinsho Byori. Japanese Journal of Clinical Pathology 33(3): 285-288Einhorn, N.; Bast, R.C.; Knapp, R.C.; Tjernberg, B.; Zurawski, V.R. 1986: Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer Obstetrics and Gynecology 67(3): 414-416
Kimura, E.; Murae, M.; Koga, R.; Odawara, Y.; Nakabayashi, Y.; Yokoyama, K.; Nakata, H.; Totake, T.; Ochiai, K.; Yasuda, M. 1984: Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 36(11): 2121-2128
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Jin, Z.; Gu, J.; Xin, X.; Li, Y.; Wang, H. 2014: Expression of hexokinase 2 in epithelial ovarian tumors and its clinical significance in serous ovarian cancer European Journal of Gynaecological Oncology 35(5): 519-524
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Stall, K.E.; Martin, E.W. 1981: Plasma carcinoembryonic antigen levels in ovarian cancer patients: a chart review and survey of published data Journal of Reproductive Medicine 26(2): 73-79
Ivanov, S.; Batashki, I. 2008: Five years survival in patients with endometrioid ovarian cancer versus patients with serous ovarian cancer Akusherstvo i Ginekologiia 47(5): 9-11
Kunze, M.; Büttner, H.H.; Strache, R.R.; Voss, P.; Briese, V.; Schrodt, U. 1988: CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors Zentralblatt für Gynakologie 110(16): 1006-1012
Kobayashi, H. 1989: The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 41(5): 585-589
Kawai, S.; Nishida, Y.; Nakada, M.; Tachikawa, M.; Miyagoshi, E. 1985: Standards of nursing of patients with ovarian and uterine cancer--through the nursing actions toward patients with cervical and ovarian cancer scheduled for total hysterectomy Nursing Technique 31(8): 1017-1024
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Rose, P.G.; Hunter, R.E. 1994: Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report Journal of Reproductive Medicine 39(11): 908-910
Fan, R.; Huang, W.; Luo, B.; Zhang, Q.M.; Xiao, S.W.; Xie, X.X. 2015: Cancer testis antigen OY-TES-1: analysis of protein expression in ovarian cancer with tissue microarrays European Journal of Gynaecological Oncology 36(3): 298-303
Tanaka, K. 1989: Ovarian cancer--assessment of methods for cytogenetic analysis and chromosome aberrations found in ovarian cancer Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 268-280
Hetzel, H.; Bichler, A.; Fuchs, D.; Hausen, A.; Reibnegger, G.; Wachter, H. 1983: Significance of urinary neopterine in gynecological oncology: follow-up of patients with ovarian cancer Cancer Detection and Prevention 6(1-2): 263-266
Jacobs, I.J.; Smith, S.A.; Wiseman, R.W.; Futreal, P.A.; Harrington, T.; Osborne, R.J.; Leech, V.; Molyneux, A.; Berchuck, A.; Ponder, B.A. 1993: A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus Cancer Research 53(6): 1218-1221
Krommer, K. 1992: Treatment of patients with advanced ovarian cancer at the Gynecological Clinic of Pécs Medical University Orvosi Hetilap 133(19): 1151-1158
Capobianco, G.; Marras, V.; Battista Meloni, G.; Dessole, S.; Ashqar, N.; Cherchi, C.; Dessole, F.; Cherchi, P.L. 2012: Immunohistochemical evaluation of a new epithelial antigen, BER-EP4 in ovarian cancer: a propos of 62 cases European Journal of Gynaecological Oncology 33(1): 90-92
Zhyl'chuk, V.I.; Alistratov, O.V.; Vorontsova, A.L. 1998: The evaluation of the efficacy of adjuvant laferon therapy in the combined treatment of patients with ovarian cancer based on the monitoring of the tumor marker Ca-125 in the blood serum Likars'ka Sprava 2: 137-139